QQQ   290.14 (-2.07%)
AAPL   143.01 (-2.00%)
MSFT   242.26 (-2.38%)
META   147.61 (-2.72%)
GOOGL   96.90 (-2.49%)
AMZN   100.56 (-1.64%)
TSLA   167.73 (-5.72%)
NVDA   192.41 (-5.52%)
NIO   12.01 (-5.51%)
BABA   111.78 (-5.58%)
AMD   72.53 (-3.81%)
T   20.10 (+0.75%)
MU   61.92 (-3.05%)
F   12.89 (-2.86%)
CGC   2.86 (-2.39%)
GE   80.78 (-2.94%)
DIS   107.93 (-1.47%)
AMC   4.99 (-9.44%)
PFE   43.40 (-0.89%)
PYPL   80.03 (-2.20%)
NFLX   353.20 (-2.10%)
QQQ   290.14 (-2.07%)
AAPL   143.01 (-2.00%)
MSFT   242.26 (-2.38%)
META   147.61 (-2.72%)
GOOGL   96.90 (-2.49%)
AMZN   100.56 (-1.64%)
TSLA   167.73 (-5.72%)
NVDA   192.41 (-5.52%)
NIO   12.01 (-5.51%)
BABA   111.78 (-5.58%)
AMD   72.53 (-3.81%)
T   20.10 (+0.75%)
MU   61.92 (-3.05%)
F   12.89 (-2.86%)
CGC   2.86 (-2.39%)
GE   80.78 (-2.94%)
DIS   107.93 (-1.47%)
AMC   4.99 (-9.44%)
PFE   43.40 (-0.89%)
PYPL   80.03 (-2.20%)
NFLX   353.20 (-2.10%)
QQQ   290.14 (-2.07%)
AAPL   143.01 (-2.00%)
MSFT   242.26 (-2.38%)
META   147.61 (-2.72%)
GOOGL   96.90 (-2.49%)
AMZN   100.56 (-1.64%)
TSLA   167.73 (-5.72%)
NVDA   192.41 (-5.52%)
NIO   12.01 (-5.51%)
BABA   111.78 (-5.58%)
AMD   72.53 (-3.81%)
T   20.10 (+0.75%)
MU   61.92 (-3.05%)
F   12.89 (-2.86%)
CGC   2.86 (-2.39%)
GE   80.78 (-2.94%)
DIS   107.93 (-1.47%)
AMC   4.99 (-9.44%)
PFE   43.40 (-0.89%)
PYPL   80.03 (-2.20%)
NFLX   353.20 (-2.10%)
QQQ   290.14 (-2.07%)
AAPL   143.01 (-2.00%)
MSFT   242.26 (-2.38%)
META   147.61 (-2.72%)
GOOGL   96.90 (-2.49%)
AMZN   100.56 (-1.64%)
TSLA   167.73 (-5.72%)
NVDA   192.41 (-5.52%)
NIO   12.01 (-5.51%)
BABA   111.78 (-5.58%)
AMD   72.53 (-3.81%)
T   20.10 (+0.75%)
MU   61.92 (-3.05%)
F   12.89 (-2.86%)
CGC   2.86 (-2.39%)
GE   80.78 (-2.94%)
DIS   107.93 (-1.47%)
AMC   4.99 (-9.44%)
PFE   43.40 (-0.89%)
PYPL   80.03 (-2.20%)
NFLX   353.20 (-2.10%)
NASDAQ:BIAF

bioAffinity Technologies - BIAF Stock Forecast, Price & News

$2.78
-0.09 (-3.14%)
(As of 01/30/2023 03:36 PM ET)
Add
Compare
Today's Range
$2.63
$3.06
50-Day Range
$1.52
$3.06
52-Week Range
$1.31
$15.55
Volume
234,629 shs
Average Volume
4.13 million shs
Market Capitalization
$7.59 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

BIAF stock logo

About bioAffinity Technologies (NASDAQ:BIAF) Stock

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.

Receive BIAF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for bioAffinity Technologies and its competitors with MarketBeat's FREE daily newsletter.

BIAF Stock News Headlines

BIAF bioAffinity Technologies, Inc.
Profit From the Commercial Solar Boom?
Solar energy had its best year ever in 2021, with a record 24 gigawatts of power installed. That's enough to power 18 million homes! Analysts expect the global solar farm market to reach $356 billion by 2028. The utility segment of the solar market is expected to grow at the highest annual growth rate in the industry, especially with the many tax incentives now offered.
"We need batteries. Literally everywhere."
Pretty much every technological megatrend today requires batteries. That includes EVs... 5G... AI... charging stations... and smart energy storage systems. Find out why the U.S. just added graphite to a list of super-critical minerals, calling it "essential for America's National Defense."
bioAffinity Technologies Inc.
Nasdaq Surges Over 150 Points; Gold Rises 2%
BioAffinity Publishes Peer Results
BioAffinity Technologies Shares Spike
bioAffinity Technologies Inc (BIAF)
San Antonio biotech goes public raising nearly $8M
bioAffinity Technologies Inc
bioAffinity Technologies, Inc. (BIAF)
bioAffinity Technologies IPO Opens Sharply Higher
Lung cancer test developer bioAffinity prices $8M IPO
BioAffinity stock soars over 150% following $8M IPO
See More Headlines
Receive BIAF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for bioAffinity Technologies and its competitors with MarketBeat's FREE daily newsletter.

BIAF Company Calendar

Last Earnings
11/14/2022
Today
1/30/2023
Next Earnings (Estimated)
9/01/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Commercial physical research
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:BIAF
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$7.59 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Ms. Maria Zannes J.D. (Age 67)
    Founder, Pres, CEO & Director
    Comp: $227.2k
  • Dr. Vivienne I. Rebel M.D. (Age 58)
    Ph.D., Exec. VP and Chief Medical & Science Officer
    Comp: $236.59k
  • Mr. Michael Edwards CPA (Age 56)
    M.B.A., Chief Financial Officer
  • Mr. Xavier T. Reveles M.S.
    VP of Operations
  • Mr. Timothy P. Zannes J.D. (Age 70)
    Exec. VP, Sec. & Gen. Counsel
  • Dr. William Bauta Ph.D.
    Sr. VP of Therapeutics













BIAF Stock - Frequently Asked Questions

How have BIAF shares performed in 2023?

bioAffinity Technologies' stock was trading at $1.60 at the beginning of the year. Since then, BIAF shares have increased by 73.8% and is now trading at $2.78.
View the best growth stocks for 2023 here
.

When is bioAffinity Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, September 1st 2023.
View our BIAF earnings forecast
.

How were bioAffinity Technologies' earnings last quarter?

bioAffinity Technologies, Inc. (NASDAQ:BIAF) posted its quarterly earnings results on Monday, November, 14th. The company reported ($1.10) EPS for the quarter.

When did bioAffinity Technologies IPO?

(BIAF) raised $8 million in an IPO on Thursday, September 1st 2022. The company issued 1,300,000 shares at $6.00-$6.25 per share. WallachBeth Capital acted as the underwriter for the IPO and Craft Capital Management was co-manager.

What is bioAffinity Technologies' stock symbol?

bioAffinity Technologies trades on the NASDAQ under the ticker symbol "BIAF."

When does bioAffinity Technologies' lock-up period expire?

bioAffinity Technologies' lock-up period expires on Tuesday, February 28th. bioAffinity Technologies had issued 1,282,600 shares in its public offering on September 1st. The total size of the offering was $7,862,338 based on an initial share price of $6.13. Shares of the company owned by company insiders and major shareholders will be eligible for trade following the end of the lock-up period.

How do I buy shares of bioAffinity Technologies?

Shares of BIAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is bioAffinity Technologies' stock price today?

One share of BIAF stock can currently be purchased for approximately $2.78.

How much money does bioAffinity Technologies make?

bioAffinity Technologies (NASDAQ:BIAF) has a market capitalization of $7.59 million.

How can I contact bioAffinity Technologies?

The official website for the company is www.bioaffinitytech.com. The company can be reached via email at jnugent@tiberend.com.

This page (NASDAQ:BIAF) was last updated on 1/30/2023 by MarketBeat.com Staff